Episode 476: MS in the Workplace with Dana Foote

What happens when you're diagnosed with a chronic, unpredictable condition just as your career is taking off? That's exactly what happened to my guest, Dana Foote.

This week, Dana joins us to share her journey from hiding her MS diagnosis as a young auditor at one of the largest accounting organizations in the world to becoming National Managing Partner for Audit & Assurance Operations and a leader in the MS community.

We'll also update you on the status of a disease-modifying therapy that has been submitted to the FDA for review as a potential treatment for relapsing MS and primary progressive MS.

We're sharing details of the National MS Society's recent $8.9 million investment to support 15 cutting-edge research projects.

We'll tell you about a study that shows physical therapy can produce confirmed disability improvement for people living with MS.

And we'll remind you that with MSToronto 2026 just one week away, you can still register for Patient Community Day.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week:  Managing MS in a demanding, high-stakes work environment  :22

The FDA grants fenebrutinib Priority Review status   1:22

The National MS Society announced $8.9 million in new research investments   4:53

A study shows ongoing physical therapy can lead to confirmed disability improvement   9:12

We're one week away from MSToronto 2026. Will you be part of Patient Community Day?  13:40